Elsevier Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Rosenberg
    Rosenberg
  5. Iyer
    Iyer
  6. Solit
    Solit
  7. Feldman
    Feldman
  8. Morris
    Morris
  9. Slovin
    Slovin
  10. Voss
    Voss

Groups

  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)
  7. Urology (54)
  8. Hematologic Malignancies, Division of (49)
  9. Human Oncology and Pathogenesis Program (49)
  10. Department of Pathology and Laboratory Medicine (46)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (245)
  2. Meeting Abstract (120)
  3. Review (7)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)

More Groups

People
  1. Robert Motzer (89)
  2. Howard Scher (72)
  3. Dean Bajorin (50)
  4. Jonathan Rosenberg (39)
  5. David Solit (33)
  6. Gopakumar Iyer (33)

More People

Years
  1. 2025 (9)
  2. 2024 (31)
  3. 2023 (12)
  4. 2022 (18)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. European Journal of Cancer (96)
  2. Clinical Genitourinary Cancer (63)
  3. Urologic Oncology: Seminars and Original Investigations (49)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Seminars in Oncology (41)
  6. Hematology/Oncology Clinics of North America (10)

More Publications

Results (384)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of theranostics in prostate cancer
    Review

    O'Dwyer, E.; Bodei, L.; Morris, M. J.
    Seminars in Radiation Oncology (2021)

    Fulltext@MSK | Save
  • Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
    Journal Article

    Oaknin, A.; Friedman, C. F.; Roman, L. D.; D'Souza, A.; Brana, I.; Bidard, F. C.; Goldman, J.; Alvarez, E. A.; Boni, V.; ElNaggar, A. C.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Unfavorable cancer-specific survival after neoadjuvant chemotherapy and radical cystectomy in patients with bladder cancer and squamous cell variant: A multi-institutional study
    Journal Article

    Bandini, M.; Pederzoli, F.; Madison, R.; Briganti, A.; Ross, J. S.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; Sridhar, S. S.; more...
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: A 12-year experience
    Journal Article

    Iyer, G.; Tully, C. M.; Zabor, E. C.; Bochner, B. H.; Dalbagni, G.; Herr, H. W.; Donat, S. M.; Russo, P.; Ostrovnaya, I.; Regazzi, A. M.; more...
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Patterns of self-reported care in a cohort of prostate cancer survivors: Implications for risk-stratified care
    Journal Article

    Nekhlyudov, L.; Blackmon, J. E.; Kantoff, P.; Recklitis, C. J.
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
    Review

    Andreatos, N.; Iyer, G.; Grivas, P.
    Cancer Treatment and Research Communications (2020)

    Fulltext@MSK | Save
  • A phase I trial of IGF-1R inhibitor cixutumumab and mTOR inhibitor temsirolimus in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D. J.; Chudow, J.; DeNunzio, M.; Slovin, S. F.; Danila, D. C.; Morris, M. J.; Scher, H. I.; Rathkopf, D. E.
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Androgens and overall survival in patients with metastatic castration-resistant prostate cancer treated with docetaxel
    Journal Article

    Ryan, C. J.; Dutta, S.; Kelly, W. K.; Middleberg, R.; Russell, C.; Morris, M. J.; Taplin, M. E.; Halabi, S.; the Alliance for Clinical Trials in Oncology Genitourinary Committee
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing
    Journal Article

    Vlachostergios, P. J.; Faltas, B. M.; Carlo, M. I.; Nassar, A. H.; Alaiwi, S. A.; Sonpavde, G.
    Cancer Treatment and Research Communications (2020)

    Fulltext@MSK | Save